GDU Women's Oncology
Press Release

HMP Global Announces Expansion into Women’s Oncology

October 28, 2020
Multi-pronged approach includes launch of Great Debates & Updates educational series and expanded, dedicated content through the award-winning Oncology Learning Network

MALVERN PA, OCTOBER 28, 2020 – As part of its continued mission to connect the global healthcare community with clinically relevant information and education that improves patient care, HMP Global, a leading healthcare event and education company, today announced a significant expansion into the field of women’s oncology.

As part of this foray, the company is making deep investments in the development of specialized content for clinicians who focus on treating women’s cancers—breast, ovarian, cervical, vaginal, and uterine. The plan includes the launch of an interactive educational series and the formation of new partnerships—all with an eye on enhancing learning and promoting rigorous exchange around groundbreaking research and treatments. 

In 2021, the company will produce the educational series, Great Debates & Updates in Women’s Oncology—an extension of the well-respected educational programming long offered in the fields of GI Cancer and Hematology. Chaired by Erika P. Hamilton, MD, director, Breast Cancer and Gynecologic Cancer Research Program, Sarah Cannon Research Institute at Tennessee Oncology, and Kathleen N. Moore, MD, associate professor, Stephenson Cancer Center at the University of Oklahoma College of Medicine, and director, Drug Development, Sarah Cannon Research Institute at the Stephenson Cancer Center, the Great Debates in Women’s Oncology series will take place online April 23-24 and October 8-9, 2021. Other meeting formats are planned for subsequent years. 

“Along with Dr. Moore, I am honored to be serving as Chair for this important new educational series,” said Dr. Hamilton. “With Breast Cancer Awareness Month as backdrop, we found this announcement particularly relevant as we take time to promote the importance of early detection and screening and spotlight advances in new therapies. Women’s cancers remain a critical area of study and research, with many unmet needs and urgent questions to be addressed. Through the power of education and collaboration, we will strengthen understanding and exchange, and pursue our shared mission of prevention, better treatments, and improved outcomes.”

Expanded content on women’s cancers will be delivered daily through the company’s award-winning Oncology Learning Network, the premier digital destination for the field, that features breaking news, relevant insight, and expert analysis, as guided by input from leading oncologists.

“HMP Global’s expansion into Women’s Oncology further underscores our commitment to translating promising research and data into practical application for clinical practice,” said Dan Lowrie, president, Imedex, a medical education subsidiary of HMP Global. “As oncologists continue to navigate the complexities of patient care, they will benefit from this education and insight that can improve decision-making and provide the highest quality, patient-centered care.”

For more information about the Great Debates & Updates educational series, visit greatdebatesandupdates.com.

ABOUT HMP GLOBAL

HMP Global is the force behind Healthcare Made Practical—and is a multichannel leader in healthcare events and education, with a mission to improve patient care. The company produces accredited medical education events, in-person and online, and clinically relevant, evidence-based content for the global healthcare community across a range of therapeutic areas. Its brands include Consultant360, the year-round, award-winning platform relied upon by primary care providers and other specialists; Psych Congress, the largest independent mental health meeting in the U.S.; EMS World Expo, the world’s largest EMS-dedicated event; and the Symposium on Advanced Wound Care (SAWC), the largest wound care meeting in the world. For more information, visit hmpglobal.com.